New York, July 17, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Active Pharmaceutical Ingredients (APIs) Market - Global Outlook ...

New York, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Active Pharmaceutical Ingredients (API) Global Market - Forecast To ...

Kotak Alternative Asset Managers, Kotak Mahindra Group’s alternative assets management entity, has invested ₹1,445 crore to partly finance the acquisition of US-based pharmaceutical major Viatris’ ...

Kotak Alternate Asset Managers Limited (Kotak Alt), announced an investment of Rs. 1,445 crore for acquisition of API business of Viatris by Matrix Pharma Private Limited (Matrix). The acquisition has ...

Pharmaceutical Technology® spoke with Dr. Weite Oldenziel, CEO of Ofichem, before CPHI Frankfurt 2025 to get his perspective on the API market and why it is important to qualify API suppliers. APIs ...

The Active Pharmaceutical Ingredient (API) Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As industries ...

Kotak Alternate Asset Managers, on Tuesday, said that it has invested Rs 1445 crore in the acquisition of Viatris' API business by Matrix Pharma Private. The acquisition was completed through the ...

Recipharm is pleased to announce that it has signed an agreement with Daewoong, the leading Korean based pharmaceutical company with a strong presence in respiratory therapeutics, for a ten year ...

Kotak Alternate Asset Managers Ltd. has announced an investment of ₹1,445 crore for acquisition of API business of Viatris by Matrix Pharma Private Ltd. The acquisition has been consummated by the ...